USPTO serial 79095590
VIARDO
Reviewed by CopyMark Law Group
Reg. 4310980Status 404
- Filing date
- Status date
- Registration date
- Apr 2, 2013
- Examiner
- STRUCK, ROBERT J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with VIARDO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Obshchestvo s ogranichennoy otvetstvennostyu "Brendlain"
RU
Other trademarks owned by Obshchestvo s ogranichennoy otvetstvennostyu "Brendlain"
Otkrytoe aktsionernoe obschchestvo Zavod ekologicheskoy tekhniki i ekopitaniya "DIOD"
RU
Otkrytoe aktsionernoe obschchestvo Zavod ekologicheskoy tekhniki i ekopitaniya "DIOD"
RU
Otkrytoe aktsionernoe obschchestvo Zavod ekologicheskoy tekhniki i ekopitaniya "DIOD"
RU
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Sanitary preparations for medical purposes; dietetic substances adapted for medical use, namely, food for babies; plasters, namely, medical materials for dressings; material for stopping teeth, namely, dental wax; disinfectants for sanitary purposes; preparations for destroying vermin; fungicides, herbicides; alkaloids for medical purposes; algaecides; aldehydes for pharmaceutical purposes; dental amalgams of gold; dental amalgams; amino acids for veterinary purposes; amino acids for medical purposes; antibiotics; aluminum acetate for pharmaceutical purposes; acetates for pharmaceutical purposes; germicides; balms for medical purposes; hygienic bandages; bandages for dressings; biocides; magnetic bracelets for medical purposes; magnetic anti-rheumatism bracelets; bromine for pharmaceutical purposes; fly catching paper; mothproofing paper; petroleum jelly for medical purposes; vaccines; oxygen baths for medical purposes; antiseptic cotton; absorbent cotton for medical purposes; absorbent wadding for medical use; cotton for medical purposes, wadding for medical purposes; radiological contrast substances for medical purposes; nutritive substances for microorganisms; radioactive substances for medical purposes; bismuth subnitrate for pharmaceutical purposes; Melissa water for pharmaceutical purposes; sea water for medicinal bathing; mineral water for medical purposes; thermal water for medical purposes; non-nutritive edible plant fiber for use as a dietary supplement; molding wax for dentists; gases for medical purposes; guaiacol for pharmaceutical purposes; haematogen; hemoglobin; hydrastine; hydrastinine; glycerin for medical purposes; glycerophosphates for medical use; glucose for medical purposes; gentian for pharmaceutical purposes; hormones for medical purposes; mustard for pharmaceutical purposes; mustard plasters for medical use; mud for baths for medical purposes; medicinal mud; gamboges for medical purposes; gurjun balsam for medical purposes; deodorants for clothing and textiles; diastase for medical purposes; digitalin; additives to fodder for medical purposes; mineral food-supplements; nutritional additives for medical purposes; yeast for pharmaceutical purposes; gelatin for medical purposes; cod liver oil; isotopes for medical purposes; insecticides; iodine for pharmaceutical purposes; iodides for pharmaceutical purposes; alkaline iodides for pharmaceutical purposes; iodoform for medical or dental use; calomel for medical use; cream of tartar for pharmaceutical purposes; tartar for pharmaceutical purposes; camphor for medical purposes; capsules sold empty for medicines; cachets for pharmaceutical purposes; candy for medical purposes, lozenges for pharmaceutical purposes, pastilles for pharmaceutical purposes; haemostatic pencils for medical use; wart pencils for medical purposes; caustic pencils for medical use; carbolineum or parasiticide for medical purposes; caustics for pharmaceutical purposes; cachou for pharmaceutical purposes; quassia for medical purposes; quebracho for medical purposes; oxygen for medical purposes; gallic acid for pharmaceutical purposes; acids for pharmaceutical purposes; adhesives for dentures; adhesive bands for medical purposes, adhesive tapes for medical purposes; collodion for pharmaceutical purposes; corn rings for the feet; anti-rheumatism rings; candy, namely, medicated candy; angostura bark for medical purposes; barks for pharmaceutical purposes; cedar wood for use as an insect repellent; condurango bark for medical purposes; croton bark for medical use; mangrove bark for pharmaceutical purposes; myrobalan bark for pharmaceutical purposes; cinchona for medical purposes; medicinal roots; rhubarb roots for pharmaceutical purposes; lint for medical purposes; starch for dietetic or pharmaceutical purposes; creosote for pharmaceutical purposes; blood for medical purposes; cultures of microorganisms for medical and veterinary use; curare for medical purposes; dental lacquer; liquorices for pharmaceutical purposes; lactose for medical purposes; adhesive plaster for medical purposes; medicines for alleviating constipation; lecithin for medical purposes; lotions for veterinary purposes; lotions for pharmaceutical purposes; lupulin for pharmaceutical purposes; magnesia for pharmaceutical purposes; liniments; medicated sunburn ointments; frostbite salve for pharmaceutical purposes; gauze for dressings; anti-horse-fly oils; medicinal oils; mustard oil for medical purposes; camphor oil for medical purposes; castor oil for medical purposes; oil of turpentine for pharmaceutical purposes; dill oil for medical purposes; dental mastics; dental abrasives; dental impression materials; teeth filling material; medical dressings for wounds; surgical dressings; serotherapeutic medicines; medicines for human purposes, namely, for normalizing male urogenital system functions, improving male sex hormones generation, and normalizing testosterone levels; menthol for pharmaceutical purposes; medicinal drinks; moleskin for medical purposes; albuminous milk for medical use; milk of almonds for pharmaceutical purposes; royal jelly for medical purposes; milk ferments for pharmaceutical purposes; Irish moss for medical purposes; nutrition based lacteal flour for babies; flour for pharmaceutical purposes, meal for pharmaceutical purposes; linseed meal for pharmaceutical purposes; fishmeal for pharmaceutical purposes; fly catching adhesives for catching insects, fly glue strips for catching insects; mint for pharmaceutical purposes; first-aid boxes or kits, filled; medicine cases for first aid kits, portable, filled; dietetic beverages adapted for medical purposes; malted milk beverages for medical purposes; prescriptive synthetic narcotics; medicinal infusions for normalizing male urogenital system functions, improving male sex hormones generation, and normalizing testosterone levels ; tincture of iodine; eucalyptol for pharmaceutical purposes; medicinal alcohol, namely, tinctures for medical purposes; opium alkaloid preparations; opodeldoc; decoctions for pharmaceutical purposes, namely, for normalizing male urogenital system functions, improving male sex hormones generation, and normalizing testosterone levels; antiparasitic collars for animals; stick liquorices for pharmaceutical purposes; sulphur sticks for use as disinfectants; pants, absorbent, for incontinents; pectin for pharmaceutical purposes; napkins for incontinents; pepsins for pharmaceutical purposes; peptones for pharmaceutical purposes; hydrogen peroxide for medical purposes; pills for pharmaceutical purposes, namely, dietetic pills for use as a supplemental source of phytosterol, vitamin E, polyunsaturated fatty acids and microelements; leeches for medical purposes; blood plasma; plasters for medical purposes; eyepatches for medical purposes; poultices; medicated compresses; scapulars for surgical purposes; bunion pads; breast-nursing pads; pomades for medical purposes; powder of cantharides; pyrethrum powder; belts for sanitary napkins or towels; anti-uric preparations; bacterial preparations for medical and veterinary use; bacteriological preparations for medical and veterinary use; balsamic preparations for medical purposes; albuminous preparations for medical purposes; biological preparations for medical purposes, namely, capsules and pills for normalizing male urogenital system functions, improving male sex hormones generation, and normalizing testosterone levels; bismuth preparations for pharmaceutical purposes; vitamin preparations; diagnostic preparations for medical purposes; therapeutic medicated preparations for the bath; haemorrhoid preparations; preparations for the treatment of burns, namely, burn relief medication; fumigation preparations for medical purposes; opotherapy preparations for medical use; air freshening preparations; air purifying preparations; bronchodilating preparations; sanitary sterilizing preparations; soil-sterilizing preparations for the control of insects; pharmaceutical preparations for treating dandruff; medical preparations for destroying noxious animals, namely, pesticides; pharmaceutical preparations for destroying dry rot fungus; larvae exterminating preparations; fly destroying preparations; preparations for destroying mice; slug exterminating preparations; pharmaceutical preparations for skin care; contact lens cleaning preparations; preparations of lime for pharmaceutical purposes; bath preparations, medicated; medicinal hair growth preparations; pharmaceutical preparations for the treatment of opiates; anticryptogamic preparations; preparations of trace elements for human and animal use, to be used as vitamin, phytosterol, fatty acid, and metal supplements; sulphonamides medicines; pharmaceutical preparations, namely, preparations contributing to normalization of male urogenital system functions and male sex hormones generation improvement, preparations contributing to normalization of testosterone level; sunburn preparations for pharmaceutical purposes, namely, medicated sunburn lotions; enzyme preparations for veterinary purposes; enzyme preparations for medical purposes; chemico-pharmaceutical preparations, namely, preparations contributing to normalization of male urogenital system functions and male sex hormones generation improvement, preparations contributing to normalization of testosterone level; chemical preparations for veterinary purposes; chemical preparations for the diagnosis of pregnancy, namely, pregnancy test kits for home use; chemical preparations to treat wheat blight or smut; vine disease treating chemicals; chemical preparations to treat mildew; chemical preparations for treating phylloxera; chemical preparations for pharmaceutical purposes; chilblain medical preparations; mothproofing preparations; eye-wash medical preparations; goulard water, namely, lead water for medical purposes; chemical conductors for electrocardiograph electrodes; albuminous foodstuffs for medical purposes; dietetic foods adapted for medical purposes; by-products of the processing of cereals for medical purposes; menstruation bandages, sanitary pads; panty liners for sanitary use; radium for medical purposes; hydrated chloral for pharmaceutical purposes; solvents for removing adhesive plasters for medical purposes; medical vaginal washes; solutions for contact lenses; chemical reagents for medical or veterinary purposes; gum for medical purposes; rubber for dental purposes; chewing gum for medical purposes; insect repellent incense; insect repellents; repellents for dogs; sanitary napkins, sanitary towels; tissues impregnated with pharmaceutical lotions; sarsaparilla for medical purposes; sugar for medical purposes; asthmatic tea; fumigating pastilles, fumigating sticks; medical suppositories; linseed for pharmaceutical purposes; tobacco-free cigarettes for medical purposes; siccatives or drying agents for medical purposes; syrups for pharmaceutical purposes; turpentine for pharmaceutical purposes; milking grease for medical purposes; greases for veterinary purposes; greases for medical purposes; soporifics for the treatment of animal; bicarbonate of soda for pharmaceutical purposes; salts for mineral water baths for medical use; bath salts for medical purposes; salts for medical purposes; potassium salts for medical purposes; sodium salts for medical purposes; smelling salts; mineral water salts for medical purposes; malt for pharmaceutical purposes; semen for artificial insemination; alcohol for pharmaceutical purposes; alloys of precious metals for dental purposes; ergot for pharmaceutical purposes; medical anesthetics; antiseptics; analgesics; adjuvants for medical purposes; styptic preparations for medical use; anthelmintics; disinfectants for hygiene purposes; disinfectants for chemical toilets; appetite suppressants for medical purposes; medical preparations for slimming purposes; parasiticides; mouthwashes for medical purposes; febrifuges; depuratives for the body; animal washes; detergents for medical purposes; cattle washes for medical purposes; dog washes for medical purposes; vesicants; headache pencils; medical remedies for perspiration; chemical contraceptives; antiparasitic preparations; evacuants, laxatives, purgatives; tonics as medicines; nervines for medical use; digestives for pharmaceutical purposes; bouillons for bacteriological cultures, media for bacteriological cultures; steroids; strychnine; medicated lozenges, namely, sal ammoniac lozenges; menstruation pads, menstruation tampons; vulnerary sponges; thymol for pharmaceutical purposes; surgical cloth tissues, surgical tissues; sedatives, tranquillizers; surgical implants living tissues; menstruation knickers, sanitary knickers, sanitary panties; charcoal for pharmaceutical purposes; fennel for medical purposes; porcelain for dental prostheses; phenol for pharmaceutical purposes; enzymes for veterinary purposes; enzymes for medical purposes; ferments for pharmaceutical purposes; formic aldehyde for pharmaceutical purposes; phosphates for pharmaceutical purposes; quinine for medical purposes; chinoline for medical purposes; diabetic bread; chloroform; flowers of sulphur for pharmaceutical purposes; cement for animal hooves; bone cement for surgical and orthopaedic purposes; dental cements; herbal teas for medicinal purposes; medicinal tea; reducing tea for medical purposes; eucalyptus for pharmaceutical purposes; tobacco extracts for insecticides use; extracts of hops for pharmaceutical purposes; ethers for pharmaceutical purposes; esters for pharmaceutical purposes; cellulose esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; medicated jujube, namely, plant extracts for pharmaceutical purposes; rat poison; bacterial poisons; jalap for use as a purgative; biologically active food additives for nutritional use | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Obshchestvo s ogranichennoy otvetstvennostyu "Brendlain"
- Other trademarks owned by Otkrytoe aktsionernoe obschchestvo Zavod ekologicheskoy tekhniki i ekopitaniya "DIOD"
- Other trademarks owned by Otkrytoe aktsionernoe obschchestvo Zavod ekologicheskoy tekhniki i ekopitaniya "DIOD"
- Other trademarks owned by Otkrytoe aktsionernoe obschchestvo Zavod ekologicheskoy tekhniki i ekopitaniya "DIOD"
- Other trademarks in Class 005
- Similar marks named VIARDO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 14, 2021 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Aug 14, 2021 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Sep 12, 2020 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 13, 2020 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Aug 13, 2020 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jul 8, 2020 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 8, 2019 | C71T | CANCELLED SECTION 71 | — |
| Apr 2, 2018 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 27, 2015 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jul 27, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 5, 2013 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 5, 2013 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 2, 2013 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 2, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 7, 2013 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 15, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 15, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 26, 2012 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 26, 2012 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 26, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 10, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 7, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 4, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 4, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 4, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 13, 2012 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 26, 2012 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 26, 2012 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 17, 2012 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 17, 2012 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 17, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 7, 2012 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jul 29, 2012 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jul 16, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 11, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 21, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 21, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 15, 2012 | ALIE | ASSIGNED TO LIE | — |
| Jun 4, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 5, 2011 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 5, 2011 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 5, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 27, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 26, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 26, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 1, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| May 13, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 28, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 28, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 28, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 27, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 26, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 23, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 22, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 21, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |